The Relationship among Pore-Size Ratings, Bubble Points, and Porosity - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Relationship among Pore-Size Ratings, Bubble Points, and Porosity


Pharmaceutical Technology


35. EMEA CPMP/QMP/489/95, Note For Guidance in Manufacture of the Finished Dosage Form, 5-6 (April reissue 1996).

36. J.P. Agalloco, "Guest Editorial: It Just Doesn't Matter," PDA J. Pharm. Sci. Technol. 52 (4), 149–150 (1998).

37. Society of Automotive Engineers (SAE), Bubble Point Test. Method, Aerospace Recommended Practice ARP-901 (1968).

38. M.W. Jornitz and T.H. Meltzer, Filtration Handbook: Integrity Testing (PDA, Bethesda, MD; DHI Publishing, River Grove, IL, 2003).

39. D.B. Pall, "Quality Control of Absolute Bacteria Removal Filters," Bull. PDA 29, 192–212 (1975).

40. A. Baszkin, D.J. Lyman, and T.H. Meltzer, "Theoretical Considerations of BubblePoint Measurement: Solid/Liquid Wetting Interaction," Pharm. Technol. Int. 2 (l), 22–31 (1978).

41. P.R. Johnston and T.H. Meltzer, "Comments on Organism Challenge Levels in Sterilizing-Filter Efficiency Testing," Pharm. Technol. 3 (11), 66–70, 110 (1979).

42. W.J. Elford, "The Principles of Ultrafiltration as Applied in Biological Studies," Proceedings of the Royal Society, 112B (London, UK, 1933), pp. 384–406.

43. A.R. Reti, "An Assessment of Test Criteria in Evaluating the Performance and Integrity of Sterilizing Filters," Bull. Paren Drug Assoc. 3l (4), 187–194 (1977).

44. D.C. Grant and J.G. Zahke, "Sieving Capture of Particles by MicroporousMembrane Filters From Clean Liquids," Swiss Contamin. Control 3 (4a), 160–164 (1990).

45. M.L. Roberts and D.J. Valazquez, "Characterizing the Rating and Performance of Membrane Filter for Liquid Applications Using Latex Spheres," Swiss Contam. Quarterly 3, 71–74 (1990).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here